{
  "pmid": "29365302",
  "uid": "29365302",
  "title": "Rivaroxaban in Stable Cardiovascular Disease.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Eikelboom",
      "fore_name": "John W",
      "initials": "JW",
      "name": "John W Eikelboom",
      "affiliations": [
        "Population Health Research Institute, Hamilton, ON, Canada",
        "eikelbj@mcmaster.ca"
      ]
    },
    {
      "last_name": "Connolly",
      "fore_name": "Stuart J",
      "initials": "SJ",
      "name": "Stuart J Connolly",
      "affiliations": [
        "Population Health Research Institute, Hamilton, ON, Canada"
      ]
    },
    {
      "last_name": "Yusuf",
      "fore_name": "Salim",
      "initials": "S",
      "name": "Salim Yusuf",
      "affiliations": [
        "Population Health Research Institute, Hamilton, ON, Canada"
      ]
    }
  ],
  "journal": {
    "title": "The New England journal of medicine",
    "iso_abbreviation": "N Engl J Med",
    "issn": "1533-4406",
    "issn_type": "Electronic",
    "volume": "378",
    "issue": "4",
    "pub_year": "2018",
    "pub_month": "Jan",
    "pub_day": "25"
  },
  "start_page": "397",
  "end_page": "398",
  "pages": "397-398",
  "language": "eng",
  "publication_types": [
    "Letter",
    "Comment"
  ],
  "keywords": [
    "Anticoagulants",
    "Cardiovascular Diseases",
    "Factor Xa Inhibitors",
    "Humans",
    "Rivaroxaban"
  ],
  "article_ids": {
    "pubmed": "29365302",
    "doi": "10.1056/NEJMc1714934",
    "pii": "10.1056/NEJMc1714934#SA6"
  },
  "doi": "10.1056/NEJMc1714934",
  "dates": {
    "completed": "2018-01-29",
    "revised": "2018-12-02"
  },
  "chemicals": [
    "Anticoagulants",
    "Factor Xa Inhibitors",
    "Rivaroxaban"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T15:11:42.772557",
    "pmid": "29365302"
  }
}